Acquired resistance to immunotherapy in MMR-D pancreatic cancer

Hu, ZI; Hellmann, MD; Wolchok, JD; Vyas, M; Shia, J; Stadler, ZK; Diaz, LA; O'Reilly, EM

O'Reilly, EM (reprint author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; O'Reilly, EM (reprint author), Div Solid Tumor Oncol, New York, NY 10065 USA.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018; 6 ():

Abstract

Background: MMR-D pancreatic cancer have been reported to respond to checkpoint inhibitor therapy. Here, we report the first case of acquired resistan......

Full Text Link